The effect of oleuropein from olive leaf (Olea europaea) extract on Ca2+ homeostasis, cytotoxicity, cell cycle distribution and ROS signaling in HepG2 human hepatoma cells

Food and Chemical Toxicology

Volumn 91, Issue , 2016, Pages 151-166

  Cheng, Jin Shiung ^a   Chou, Chiang Ting ^b   Liu, Yuan Yuarn ^a   Sun, Wei Chih ^a   Shieh, Pochuen ^c   Kuo, Daih Huang ^c   Kuo, Chun Chi ^d   Jan, Chung Ren ^a   Liang, Wei Zhe ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

^d TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; Ca2+; Cell cycle; Human hepatoma cells; Oleuropein; ROS

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CYCLIN B1; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; OLEA EUROPAEA EXTRACT; OLEUROPEIN; PLANT EXTRACT; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; THAPSIGARGIN; UNCLASSIFIED DRUG; IRIDOID;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CYCLE; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOTOXICITY; EXTRACELLULAR CALCIUM; HEPATOMA CELL; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL; OLIVE TREE; PLANT LEAF; PROTEIN EXPRESSION; CHEMISTRY; DRUG EFFECTS; HEP-G2 CELL LINE; HOMEOSTASIS; ISOLATION AND PURIFICATION; METABOLISM; SIGNAL TRANSDUCTION;

CALCIUM; CELL CYCLE; HEP G2 CELLS; HOMEOSTASIS; HUMANS; IRIDOIDS; OLEA; PLANT LEAVES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84962266293     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.03.015     Document Type: Article

References (77)

1. Alisi A., Balsano C. Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents. Nutr. Rev. 2007, 65:550-553.
2. Andreana L., Isgrò G., Marelli L., Davies N., Yu D., Navalkissoor S., Burroughs A.K. Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radioemitter compounds: trans-arterial radio-embolisation of HCC. Cancer Treat. Rev. 2012, 38:641-649.
3. Anter J., Fernández-Bedmar Z., Villatoro-Pulido M., Demyda-Peyras S., Moreno-Millán M., Alonso-Moraga A., Muñoz-Serrano A., Luque de Castro M.D. A pilot study on the DNA-protective, cytotoxic, and apoptosis-inducing properties of olive-leaf extracts. Mutat. Res. 2011, 723:165-170.
4. Anttila M.A., Kosma V.M., Hongxiu J., Puolakka J., Juhola M., Saarikoski S., Syrjanen K. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br. J. Cancer 1999, 79:1870-1878.
5. Baffy G., Yang L., Michalopoulos G.K., Williamson J.R. Hepatocyte growth factor induces calcium mobilization and inositol phosphate production in rat hepatocytes. J. Cell. Physiol. 1992, 153:332-339.
6. Bartek J., Lukas C., Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 2004, 5:792-804.
7. Bayomi E.A., Barakat A.B., El-Bassuoni M.A., Talaat R.M., El-Deftar M.M., Abdel Wahab S.A., Metwally A.M. Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma. J. Cancer Res. Ther. 2015, 11:786-792.
8. Beppu T., Sugimoto K., Shiraki K., Tameda M., Kusagawa S., Nojiri K., Tanaka J., Yamamoto N., Takei Y., Takaki H., Uraki J., Nakatsuka A., Yamakado K., Takeda K. Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation. Int. J. Mol. Med. 2010, 26:425-433.
9. Berridge M.J. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 2002, 32:235-249.
10. Bulotta S., Corradino R., Celano M., Maiuolo J., D'Agostino M., Oliverio M., Procopio A., Filetti S., Russo D. Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells. J. Mol. Endocrinol. 2013, 51:181-189.
11. Cao J., Dai D.L., Yao L., Yu H.H., Ning B., Zhang Q., Chen J., Cheng W.H., Shen W., Yang Z.X. Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathway. Mol. Cell. Biochem. 2012, 364:115-129.
12. Carafoli E. Calcium signalling: a tale for all seasons. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1115-1122.
13. Carluccio M.A., Siculella L., Ancora M.A., Massaro M., Scoditti E., Storelli C., Visioli F., Distante A., De Caterina R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 2003, 23:622-629.
14. 2+ homeostasis and apoptosis in SCM1 human gastric cancer cells. Arch. Toxicol. 2013, 87:2141-2150.
15. Chen Y.J., Su J.H., Tsao C.Y., Hung C.T., Chao H.H., Lin J.J., Liao M.H., Yang Z.Y., Huang H.H., Tsai F.J., Weng S.H., Wu Y.J. Sinulariolide induced hepatocellular carcinoma apoptosis through activation of mitochondrial-related apoptotic and PERK/eIF2α/ATF4/CHOP pathway. Molecules 2013, 18:10146-10161.
16. 2+-, and reactive oxygen species-dependent pathway in HepG2 human hepatocellular carcinoma cells. Apoptosis 2014, 19:682-697.
17. Cui J., Guo Y.H., Zhang H.Y., Jiang L.L., Ma J.Q., Wang W.J., Wang M.C., Yang C.C., Nan K.J., Song L.P. Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids. Onco Targets Ther. 2014, 7:353-363.
18. Darekar R.S., Khetre A.B., Singh S.M., Damle M.C. HPTLC method for quantitative evaluation of preparations containing Indian 'Elixir' plant, Tinospora cordifolia , using jatrorrhizine as marker. J. Planar Chromatogr. 2009, 22:439-443.
19. de Bock M., Thorstensen E.B., Derraik J.G., Henderson H.V., Hofman P.L., Cutfield W.S. Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Mol. Nutr. Food Res. 2013, 57:2079-2085.
20. Domitrović R., Jakovac H., Marchesi V.V., Šain I., Romić Ž., Rahelić D. Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice. Pharmacol. Res. 2012, 65:451-464.
21. El-Serag H.B., Mason A.C. Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med. 2000, 160:3227-3230.
22. +-dependent transport mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G1145-G1156.
23. Furuse J. Sorafenib for the treatment of unresectable hepatocellular carcinoma. Biologics 2008, 2:779-788.
24. Goulas V., Exarchou V., Troganis A.N., Psomiadou E., Fotsis T., Briasoulis E., Gerothanassis I.P. Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Mol. Nutr. Food Res. 2009, 53:600-608.
25. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1311.
26. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
27. Hagiwara K., Goto T., Araki M., Miyazaki H., Hagiwara H. Olive polyphenol hydroxytyrosol prevents bone loss. Eur. J. Pharmacol. 2011, 662:78-84.
28. Hamdi H.K., Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun. 2005, 334:769-778.
29. Han Y.H., Kim S.H., Kim S.Z., Park W.H. Intracellular GSH levels rather than ROS levels are tightly related to AMA-induced HeLa cell death. Chem. Biol. Interact. 2008, 171:67-78.
30. Han J., Talorete T.P., Yamada P., Isoda H. Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology 2009, 59:45-53.
31. Hassan Z.K., Elamin M.H., Omer S.A., Daghestani M.H., Al-Olayan E.S., Elobeid M.A., Virk P. Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. Asian Pac. J. Cancer Prev. 2013, 14:6739-6742.
32. Horgan A.M., Dawson L.A., Swaminath A., Knox J.J. Sorafenib and radiation therapy for the treatment of advanced hepatocellular carcinoma. J. Gastrointest. Cancer 2012, 43:344-348.
33. Hwang Y.P., Kim H.G., Choi J.H., Do M.T., Chung Y.C., Jeong T.C., Jeong H.G. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. J. Nutr. Biochem. 2013, 24:1469-1478.
34. Jeong S.Y., Seol D.W. The role of mitochondria in apoptosis. BMB Rep. 2008, 41:11-22.
35. Kajstura M., Halicka H.D., Pryjma J., Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms. Cytometry A 2007, 71:125-131.
36. Kaufmann T., Tai L., Ekert P.G., Huang D.C., Norris F., Lindemann R.K., Johnstone R.W., Dixit V.M., Strasser A. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 2007, 129:423-433.
37. Kim Y., Choi Y., Park T. Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. Biotechnol. J. 2010, 5:950-960.
38. Kim S.W., Hur W., Li T.Z., Lee Y.K., Choi J.E., Hong S.W., Lyoo K.S., You C.R., Jung E.S., Jung C.K., Park T., Um S.J., Yoon S.K. Oleuropein prevents the progression of steatohepatitis to hepatic fibrosis induced by a high-fat diet in mice. Exp. Mol. Med. 2014, 46:e92.
39. 2+ influx in the tert-butyl hydroperoxide-induced apoptosis of HepG2 human hepatoblastoma cells. Exp. Mol. Med. 1998, 30:137-144.
40. Kim J.H., Kim D., Kim J., Hwang J.K. Euchresta horsfieldii Benn. activates peroxisome proliferator-activated receptor α and regulates expression of genes involved in fatty acid metabolism in human HepG2 cells. J. Ethnopharmacol. 2011, 33:244-247.
41. Kuete V., Nkuete A.H., Mbaveng A.T., Wiench B., Wabo H.K., Tane P., Efferth T. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines. Phytomedicine 2014, 21:1651-1657.
42. Landriscina M., Maddalena F., Laudiero G., Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid. Redox Signal. 2009, 11:2701-2716.
43. Lee K.H. Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J. Nat. Prod. 2010, 73:500-516.
44. 2+ increase and cell injury in a human hepatoma cell line. Toxicol. Lett. 2012, 208:254-261.
45. Moore P.D., Yedjou C.G., Tchounwou P.B. Malathion-induced oxidative stress, cytotoxicity and genotoxicity in human liver carcinoma (HepG2) cells. Environ. Toxicol. 2010, 25:221-226.
46. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 2000, 150:887-894.
47. Nasmyth K. A prize for proliferation. Cell 2001, 107:689-701.
48. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
49. O'Connell M.J., Walworth N.C., Carr A.M. The G2-phase DNA-damage checkpoint. Trends Cell Biol. 2000, 10:296-303.
50. Pal S., Ghosh M., Ghosh S., Bhattacharyya S., Sil P.C. Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways. Food Chem. Toxicol. 2015, 83:36-47.
51. Patil C., Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 2001, 13:349-355.
52. Piacentini R., Gangitano C., Ceccariglia S., Del Fà A., Azzena G.B., Michetti F., Grassi C. Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin. J. Neurochem. 2008, 105:2109-2121.
53. Pisani P., Bray F., Parkin D.M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer 2002, 97:72-81.
54. Qurishi Y., Hamid A., Majeed R., Hussain A., Qazi A.K., Ahmed M., Zargar M.A., Singh S.K., Saxena A.K. Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer. Future Oncol. 2011, 7:1007-1021.
55. Ramsey M.R., Sharpless N.E. ROS as a tumour suppressor?. Nat. Cell Biol. 2006, 8:1213-1215.
56. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J. Leukoc. Biol. 1990, 47:440-448.
57. Roy K.R., Reddy G.V., Maitreyi L., Agarwal S., Achari C., Vali S., Reddanna P. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line. Cancer Chemother. Pharmacol. 2010, 65:903-911.
58. Shin S.Y., Yong Y., Kim C.G., Lee Y.H., Lim Y. Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis in HeLa cells. Cancer Lett. 2010, 287:231-239.
59. Shiraishi H., Okamoto H., Yoshimura A., Yoshida H. ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J. Cell Sci. 2006, 119:3958-3966.
60. 2+ signaling and apoptosis. J. Bioenerg. Biomembr. 2000, 32:35-46.
61. Soler-Rivas C., Espin J.C., Wichers H.J. Oleuropein and related compounds. J. Sci. Food Agric. 2000, 80:1013-1023.
62. Song M.O., Lee C.H., Yang H.O., Freedman J.H. Endosulfan upregulates AP-1 binding and ARE-mediated transcription via ERK1/2 and p38 activation in HepG2 cells. Toxicology 2012, 292:23-32.
63. 2+ channels in human hepatoma cells. Cancer Biother. Radiopharm. 2013, 28:320-326.
64. Visioli F., Poli A., Galli C. Antioxidant and other biological activities of phenols from olives and olive oil. Med. Res. Rev. 2002, 22:65-75.
65. Visioli F., Bellosta S., Galli C. Oleuropein, the bitter principles of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 1998, 62:541-546.
66. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
67. Vriens J., Janssens A., Prenen J., Nilius B., Wondergem R. TRPV channels and modulation by hepatocyte growth factor/scatter factor in human hepatoblastoma (HepG2) cells. Cell Calcium 2004, 36:19-28.
68. Werno C., Zhou J., Brüne B. A23187, ionomycin and thapsigargin upregulate mRNA of HIF-1alpha via endoplasmic reticulum stress rather than a rise in intracellular calcium. J. Cell. Physiol. 2008, 215:708-714.
69. Wu J.H., Batist G. Glutathione and glutathione analogues; therapeutic potentials. Biochim. Biophys. Acta 2013, 1830:3350-3353.
70. Wu J.C., Merlino G., Fausto N. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:674-678.
71. Xie R., Xu J., Wen G., Jin H., Liu X., Yang Y., Ji B., Jiang Y., Song P., Dong H., Tuo B. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. J. Biol. Chem. 2014, 289:19137-19149.
72. Yin J., Liu B., Li B., Liu Z., Xie X., Lv Z., Gao S., Guang J. The cyclooxygenase-2 inhibitor celecoxib attenuates hepatocellular carcinoma growth and c-Met expression in an orthotopic mouse model. Oncol. Res. 2011, 19:131-139.
73. Yuan Y., Jiang C.Y., Xu H., Sun Y., Hu F.F., Bian J.C., Liu X.Z., Gu J.H., Liu Z.P. Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway. Plos One 2013, 8:e64330.
74. Zafarullah M., Li W.Q., Sylvester J., Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 2003, 60:6-20.
75. Zamzami N., Kroemer G. Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis. Methods Mol. Biol. 2004, 282:103-115.
76. Zbidi H., Salido S., Altarejos J., Perez-Bonilla M., Bartegi A., Rosado J.A., Salido G.M. Olive tree wood phenolic compounds with human platelet antiaggregant properties. Blood Cells Mol. Dis. 2009, 42:279-285.
77. Zhang X., Yao Y., Lou Y., Jiang H., Wang X., Chai X., Zeng S. Metabolism of ebracteolata compound B studied in vitro with human liver microsomes, HepG2 cells and recombinant human enzymes. Drug Metab. Dispos. 2010, 38:2157-2165.